Beodeul Kang
Impact in
- Hepatology top 2%
- Hepatocellular Carcinoma Treatment and Prognosis
- Oncology top 5%
- Cancer Immunotherapy and Biomarkers
- Pancreatic and Hepatic Oncology Research
Papers in
- Hepatology 27
- Hepatocellular Carcinoma Treatment and Prognosis 27
- Oncology 21
- Cancer Immunotherapy and Biomarkers 12
- Co-authors
- Hong Jae Chon (42 shared papers)Chan Kim (24 shared papers)Jaekyung Cheon (19 shared papers)Hye Jin Choi (11 shared papers)Won Suk Lee (11 shared papers)Hyun Cheol Chung (10 shared papers)Hannah Yang (9 shared papers)Sun Young Rha (11 shared papers)
- Journals
- Cancer Research and Treatment (7 papers)Liver Cancer (5 papers)Liver International (4 papers)Therapeutic Advances in Medical Oncology (4 papers)Journal of Hepatology (3 papers)
- Partner nations
- South KoreaJapanUnited States
In The Last Decade
Beodeul Kang
84 papers receiving 1.7k citations
Beodeul Kang's Hit Papers
Peers
Comparison fields: 5 of 76
- Hepatology 518
- Oncology 443
- Surgery 277
- Pulmonary and Respiratory Medicine 181
- Immunology 100
Countries citing papers authored by Beodeul Kang
This map shows the geographic impact of Beodeul Kang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Beodeul Kang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Beodeul Kang more than expected).
Fields of papers citing papers by Beodeul Kang
This network shows the impact of papers produced by Beodeul Kang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Beodeul Kang. The network helps show where Beodeul Kang may publish in the future.
Co-authors
The 25 scholars most cited alongside Beodeul Kang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 96 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 156 | |
| 2 | Trastuzumab plus FOLFOX for HER2-positive biliary tract cancer refractory to gemcitabine and cisplatin: a multi-institutional phase 2 trial of the Korean Cancer Study Group (KCSG-HB19–14) Hit paper breakdown → | 2022 | 100 |
| 3 | 2022 | 99 | |
| 4 | 2021 | 91 | |
| 5 | 2021 | 75 | |
| 6 | 2023 | 64 | |
| 7 | 2017 | 53 | |
| 8 | 2016 | 52 | |
| 9 | 2020 | 52 | |
| 10 | 2021 | 52 | |
| 11 | Korean Practice Guidelines for Gastric Cancer 2024: An Evidence-based, Multidisciplinary Approach (Update of 2022 Guideline) Hit paper breakdown → | 2025 | 52 |
| 12 | 2022 | 47 | |
| 13 | 2024 | 46 | |
| 14 | 2022 | 44 | |
| 15 | 2013 | 40 | |
| 16 | 2024 | 38 | |
| 17 | 2020 | 36 | |
| 18 | 2020 | 35 | |
| 19 | 2022 | 34 | |
| 20 | 2021 | 33 |
About Beodeul Kang
Beodeul Kang is a scholar working on Hepatology, Oncology, Pulmonary and Respiratory Medicine, Critical Care and Intensive Care Medicine and Surgery, having authored 96 papers that have together received 1.8k indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (27 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (16 papers), Cancer Immunotherapy and Biomarkers (12 papers), Palliative Care and End-of-Life Issues (10 papers), Gastric Cancer Management and Outcomes (7 papers), Intensive Care Unit Cognitive Disorders (6 papers), Religion, Spirituality, and Psychology (3 papers) and Renal cell carcinoma treatment (3 papers). The work is most often cited by research in Hepatology (518 citations), Oncology (443 citations), Surgery (277 citations), Pulmonary and Respiratory Medicine (181 citations) and Immunology (100 citations). Beodeul Kang has collaborated with scholars based in South Korea, Japan and United States. Frequent co-authors include Hong Jae Chon, Chan Kim, Jaekyung Cheon, Hye Jin Choi, Won Suk Lee, Hyun Cheol Chung, Hannah Yang, Sun Young Rha, Ho Yeong Lim and Hyeyeong Kim. Their work appears in journals such as Cancer Research and Treatment, Liver Cancer, Liver International, Therapeutic Advances in Medical Oncology and Journal of Hepatology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.